Allworth Financial
BNTC icon

Allworth Financial’s Benitec Biopharma BNTC Stock Holding History

Allworth Financial’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$964 Buy
72
+34
+89% +$416 ﹤0.01% 4837
2026
Q2 		$509 Sell
38
-149
-80% -$1.77K ﹤0.01% 4849
2026
Q1 		$1.99K Buy
+187
New +$2.16K ﹤0.01% 4354

Other funds holding BNTC

Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
MYDA Advisors
MYDA Advisors Woodmere, New York $900M AUM 46.04% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Allworth Financial's BNTC Position: Q3 2026 in Review

Allworth Financial increased its Benitec Biopharma (BNTC) stake by 89% in Q3 2026, buying an estimated $416 and bringing the position to 72 shares worth $964. The position accounts for ﹤0.01% of the portfolio, ranked #4837.

Allworth Financial first reported a position in BNTC in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.99K in Q1 2026. 57 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • Allworth Financial held 72 shares of Benitec Biopharma worth $964 as of Q3 2026.
  • Allworth Financial bought 34 Benitec Biopharma shares in Q3 2026, an estimated $416.
  • Benitec Biopharma made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4837 holding.
  • Allworth Financial first reported a position in Benitec Biopharma in Q1 2026 and has held it in 3 quarters since.
  • Allworth Financial's Benitec Biopharma position peaked at $1.99K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.